Emfizatamab Antibody is a research-grade biosimilar monoclonal antibody targeting CD19. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays, in vivo research and Western blot. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody.